Correlation Between Regenxbio and Pharvaris

Can any of the company-specific risk be diversified away by investing in both Regenxbio and Pharvaris at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Regenxbio and Pharvaris into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Regenxbio and Pharvaris BV, you can compare the effects of market volatilities on Regenxbio and Pharvaris and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Regenxbio with a short position of Pharvaris. Check out your portfolio center. Please also check ongoing floating volatility patterns of Regenxbio and Pharvaris.

Diversification Opportunities for Regenxbio and Pharvaris

0.7

Correlation Coefficient

Regenxbio  Pharvaris

Poor diversification

The 3 months correlation between Regenxbio and Pharvaris is 0.7. Overlapping area represents the amount of risk that can be diversified away by holding Regenxbio and Pharvaris BV in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pharvaris BV and Regenxbio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Regenxbio are associated (or correlated) with Pharvaris. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pharvaris BV has no effect on the direction of Regenxbio i.e., Regenxbio and Pharvaris go up and down completely randomly.

Pair Corralation between Regenxbio and Pharvaris

Given the investment horizon of 90 days Regenxbio is expected to under-perform the Pharvaris. But the stock apears to be less risky and, when comparing its historical volatility, Regenxbio is 1.24 times less risky than Pharvaris. The stock trades about -0.04 of its potential returns per unit of risk. The Pharvaris BV is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest  810.00  in Pharvaris BV on November 19, 2024 and sell it today you would earn a total of  917.00  from holding Pharvaris BV or generate 113.21% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Regenxbio  vs.  Pharvaris BV

Regenxbio

Risk-Adjusted Performance

Very Weak

Over the last 90 days Regenxbio has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in March 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Pharvaris BV

Risk-Adjusted Performance

Very Weak

Over the last 90 days Pharvaris BV has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in March 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Pair Trading with Regenxbio and Pharvaris

The main advantage of trading using opposite Regenxbio and Pharvaris positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Regenxbio position performs unexpectedly, Pharvaris can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pharvaris will offset losses from the drop in Pharvaris' long position.

The idea behind Regenxbio and Pharvaris BV pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.